Pycap has acquired an equity position in SMYLS, a Canadian SaaS solution aimed at simplifying uninsured physician billing, enhancing its commitment to innovative healthcare technology investments.

Information on the Target: SMYLS

SMYLS is a Canadian-based, modern SaaS solution designed to streamline the often-complex process of uninsured and block billing for family physicians. The platform was developed in response to real challenges faced by healthcare practitioners, specifically the co-founder’s spouse—a physician who experienced difficulties with traditional uninsured billing practices at her clinic. This led to the creation of a user-friendly system, built by a team of experienced technologists, focused on simplifying billing processes for medical professionals.

The core capabilities of SMYLS include rapid invoicing and payment processing, automated block billing, and customizable pricing structures tailored to each physician. These features enable clinics to improve operational efficiency, enhance cash flow, and ultimately increase annual revenue—some users reporting boosts of over $100,000 per physician.

Industry Overview in Canada

The healthcare technology landscape in Canada is rapidly evolving, driven largely by advancements in digital health solutions aimed at improving patient care and administrative efficiencies. Market demand for technology-enable

View Source

Similar Deals

Pathway to Cures SeraGene Therapeutics

2025

Other VC Bio Therapeutic Drugs Canada
Malar Group EverKind

2025

Other VC Healthcare Facilities & Services (NEC) Canada
S2G Investments Mara Renewables

2025

Other VC Biotechnology & Medical Research (NEC) Canada
Pycap ChargerQuest

2024

Other VC Alternative Medicine Facilities Canada
Sun Life Canada Dialogue

2023

Other VC Telemedicine Services Canada
TVM Capital Life Science Esperas Pharma, Inc.

2023

Other VC Bio Therapeutic Drugs Canada

Pycap

invested in

SMYLS

in 2025

in a Other VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert